Summary
Vanderbilt University (Vanderbilt) is a medical and research university that provides professional degrees. The university offers graduate and undergraduate degrees in the fields of engineering, music, liberal arts and sciences, education and human development. It provides services such as clinical research and research support services. Vanderbilt’s research support services includes study organization, IRB navigation, training, protocol development, preparation of study related documents, funding and contractual agreements and overall program advisory. The university offers its services through blair school of music, divinity school, school of engineering, law school, graduate school, school of medicine, and others. Vanderbilt is headquartered in Nashville, Tennessee, the US.
Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Vanderbilt University, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Vanderbilt University, Medical Devices Deals, 2010 to YTD 2016 9
Vanderbilt University, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Vanderbilt University, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Illumina Enters into Agreement with Vanderbilt University 12
Diatherix Labs Enters into Research Agreement with Vanderbilt University Medical Center 13
MedImmune, GlaxoSmithKline and Vanderbilt University Enter into Agreement 14
BioReference Labs Enters into Co-Development Agreement with Vanderbilt-Ingram 15
Incyte Enters into Research Agreement with Vanderbilt University Medical Center 16
Vanderbilt University Enters Into Research Agreement With GlaxoSmithKline For Obesity Drug 17
Baptist Memorial Health Care Enters Into Research Agreement With Vanderbilt University 19
Vanderbilt University Enters Into Agreement With Bristol-Myers Squibb To Develop Drugs For Parkinson’s Disease 20
Scripps Research Enters Into Joint Venture Agreement With Vanderbilt University 22
Seaside Therapeutics Enters Into Research Collaboration With Vanderbilt University 24
Licensing Agreements 25
La Jolla Pharma Enters into Licensing Agreement with Vanderbilt University 25
AstraZeneca Enters into Licensing Agreement with Vanderbilt University 26
AstraZeneca Enters Into Licensing Agreement With Vanderbilt University For Neuroscience Drug Discovery 27
Parker Hannifin Enters Into Licensing Agreement With Vanderbilt University For Exoskeleton Technology 28
Nanoferix Enters into Licensing Agreement with Vanderbilt University Center for Technology Transfer and Commercialization 30
Vanderbilt University Enters Into Licensing Agreement With Karuna Pharma 31
Asset Transactions 32
Cumberland Pharma Acquires Rights Of Ifetroban From Vanderbilt University 32
Acquisition 34
Vanderbilt University Sells Microarrays 34
Vanderbilt University - Key Competitors 35
Key Employees 36
Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
List of Tables
Vanderbilt University, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Vanderbilt University, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Vanderbilt University, Deals By Therapy Area, 2010 to YTD 2016 8
Vanderbilt University, Medical Devices Deals, 2010 to YTD 2016 9
Vanderbilt University, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Illumina Enters into Agreement with Vanderbilt University 12
Diatherix Labs Enters into Research Agreement with Vanderbilt University Medical Center 13
MedImmune, GlaxoSmithKline and Vanderbilt University Enter into Agreement 14
BioReference Labs Enters into Co-Development Agreement with Vanderbilt-Ingram 15
Incyte Enters into Research Agreement with Vanderbilt University Medical Center 16
Vanderbilt University Enters Into Research Agreement With GlaxoSmithKline For Obesity Drug 17
Baptist Memorial Health Care Enters Into Research Agreement With Vanderbilt University 19
Vanderbilt University Enters Into Agreement With Bristol-Myers Squibb To Develop Drugs For Parkinson’s Disease 20
Scripps Research Enters Into Joint Venture Agreement With Vanderbilt University 22
Seaside Therapeutics Enters Into Research Collaboration With Vanderbilt University 24
La Jolla Pharma Enters into Licensing Agreement with Vanderbilt University 25
AstraZeneca Enters into Licensing Agreement with Vanderbilt University 26
AstraZeneca Enters Into Licensing Agreement With Vanderbilt University For Neuroscience Drug Discovery 27
Parker Hannifin Enters Into Licensing Agreement With Vanderbilt University For Exoskeleton Technology 28
Nanoferix Enters into Licensing Agreement with Vanderbilt University Center for Technology Transfer and Commercialization 30
Vanderbilt University Enters Into Licensing Agreement With Karuna Pharma 31
Cumberland Pharma Acquires Rights Of Ifetroban From Vanderbilt University 32
Vanderbilt University Sells Microarrays 34
Vanderbilt University, Key Competitors 35
Vanderbilt University, Key Employees 36
Vanderbilt University, Subsidiaries 37
List of Figures
Vanderbilt University, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Vanderbilt University, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Vanderbilt University, Medical Devices Deals, 2010 to YTD 2016 9
